Agoracom Blog Home

Posts Tagged ‘7-Eleven’

Datametrex $DM.ca Expands Distribution of Film and Television #Coronavirus Testing Across Canada and Provides Revenue Guidance, Top-Line Revenue Estimates From Current Work Is Approx. $20 million $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

Posted by AGORACOM-JC at 10:43 AM on Tuesday, October 27th, 2020
Webinar logo
  • Currently, supplying COVID-19 Tests for thirteen film productions launched in Vancouver, with additions in Montreal, and Toronto.
  • Currently executing over 4000 tests per week.
  • Top-line revenue estimates from the current work is approx. $20 million.

Toronto, Ontario–(October 27, 2020) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”) is pleased to update its shareholders on the growth of film and television production COVID TESTING. As Film and Television studios continue to expand productions throughout Canada, Datametrex is being requested by its current clients to take on more coronavirus testing for their portfolio of productions across the country.

The Company has also been approached by additional film and studio companies for Datametrex to assist with fulfilling the studio with their own testing needs. Based on these current contracts, and additional opportunities for testing services which the Company is pursuing and in discussions for, management believes that the Company is on track to achieve approximately 4,000 tests per week, based on current operations Datametrex, current cost and revenue model, would result in revenue of approximately $20 million over the next 28 weeks. There can be no assurance or guarantee that this revenue amount will result for the Company.

The global film and video market is expected to decline from $252.9 billion in 2019 to $244.4 billion in 2020 at a compound annual growth rate (CAGR) of -3.4%. The decline is mainly due to economic slowdown across countries owing to the COVID-19 outbreak and the measures to contain it. The market is then expected to recover and grow at a CAGR of 5% from 2021 and reach $284 billion in 2023.

(https://www.businesswire.com/news/home/20200821005370/en/Global-Film-and-Video-Market-Report-2020-to-2030—COVID-19-Impact-and-Recovery—ResearchAndMarkets.com)

Marshal Gunter, CEO, said, “I must first say thank you to the entire team at Datametrex along with the medical and lab professionals for their tireless work at the company. We are ramping up our business to meet increasing demand and our expectation based on what we are seeing in the market is to execute on approximately 10,000 tests per week on a progressive basis. We are witnessing a paradigm shift within the film industry. With the advent of movie theaters being closed in numerous regions around the globe due to government enforced shut downs by coronavirus, film and television companies rely more on at-home streaming services to maintain a robust revenue model. Content production is key to this and Canada is a major platform for content development. The demand remains high for qualified medical professionals from the private sector to be on site, and in the lab, ensuring complete and timely delivery of coronavirus tests supplied by Datametrex.” He continued, “with our growing revenue model, we remain committed to our shareholders and will announce further developments with additional conference calls and press releases in the coming weeks.”

About Datametrex

Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

Certain statements including in this news release contain “forward-looking information” or constitute “forward-looking statements” within the meaning of applicable securities laws. Such forward-looking statements or information are provided for the purpose of providing information about management’s current expectations and plans relating to the future. Readers are cautioned that reliance on such information may not be appropriate for other purposes In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy, including the dollar amount of revenue anticipated as disclosed in this press release.

Forward-looking statements or information are based on current expectations, estimates and projections that involve several risks and uncertainties, which could cause actual results to differ materially from those anticipated by the Company and described in the forward-looking statements or information. These risks and uncertainties may cause actual results to differ materially from the forward-looking statements or information.

Readers are cautioned that the foregoing list is not exhaustive of all possible risks and uncertainties. Readers are also cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the time such forward-looking information is made. Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Datametrex $DM.ca Deploys New AI Non-Contact Temperature Assessment Device and Clarifies October 1 Press Release $TMO $DGX $CEMI $QDEL

Posted by AGORACOM-JC at 9:52 AM on Thursday, October 15th, 2020
Webinar logo
  • Company has started to deploy in the market MiCovid Cam Temperature Scanners with COVID-19 testing customers
  • Product is a new AI thermal detector with facial recognition and non-contact temperature assessment device to identify and triage people who may have elevated temperatures
  • Utilizing the latest AI chipset technology, MiCovid Cam offers immediate body temperature detection, a long sensor range, and a high level of accuracy

Toronto, Ontario–(October 15, 2020) –  Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”) is pleased to announce that the Company has started to deploy in the market MiCovid Cam Temperature Scanners with COVID-19 testing customers from October 9, 2020. This product is a new AI thermal detector with facial recognition and non-contact temperature assessment device to identify and triage people who may have elevated temperatures.

Utilizing the latest AI chipset technology, MiCovid Cam offers immediate body temperature detection, a long sensor range, and a high level of accuracy. MiCovid Cam is fully integrated into Web Services API suite allowing third party and independent software developers to adopt body temperature data into their current and future software solutions. It is fast, non-contact, non-invasive and accurate so as to not delay or hamper the customer experience.

“As we potentially enter into a second wave of the COVID-19 there is a need to support the reopening of economies, and having another tool to support this with MiCovid Cam, which is a solution capable of fast tracking the safe return of customers to office buildings, restaurants, retail outlets, coffee shops, government offices, and educational institutions.”, commented Marshall Gunter CEO of the Company.

The Company issued 2,500,000 stock options with an exercise price of $0.12 to a consultant pursuant to its stock option plan on October 7, 2020.The options will expire on October 1, 2023.

The Company also wishes to clarify certain statements included in its press release dated October 1, 2020 (the “CEO Update Release“). Certain statements included in the CEO Update Release constitute “forward-looking statements” within the meaning of applicable securities laws. Forward-looking statements contained in the CEO Update Release include statements with respect to the Company’s intention regarding possibility of consolidating its common shares and the Company’s anticipated profitability. The Company cautions readers that these forward-looking statements are not historical facts and may have involved estimates, assumptions and uncertainties which could cause actual results or outcomes to differ materially from those expressed in such forward-looking statements. Specifically, forward-looking statements contained in the CEO Update Release were based on certain assumptions made by management of the Company, including with respect to the projected growth of the market for the Company’s products, the Company’s ability to meet customers’ product demand, the projected financial performance of the Company, the Company’s ability to obtain and maintain all necessary government approvals to operate its business and the absence of any unforeseen logistical delays in the Company’s growth including those related to COVID-19. No assurance can be given that these expectations will prove to be correct. Undue reliance should not be placed on the forward-looking statements included in the CEO Update Release. The forward-looking statements included in the CEO Update Release were made as of the date of the CEO Update Release. The Company has undertaken no obligation to update or revise any forward-looking statement included in the CEO Update Release to reflect events or circumstances after the date on which such statements were made or to reflect the occurrence of unanticipated events, except as required by applicable securities laws.

About Datametrex

Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:
Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

Certain statements including in this news release contain “forward-looking information” or constitute “forward-looking statements” within the meaning of applicable securities laws. Such forward-looking statements or information are provided for the purpose of providing information about management’s current expectations and plans relating to the future. Readers are cautioned that reliance on such information may not be appropriate for other purposes In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy, including the dollar amount of revenue anticipated under the Agreement.

Forward-looking statements or information are based on current expectations, estimates and projections that involve several risks and uncertainties, which could cause actual results to differ materially from those anticipated by the Company and described in the forward-looking statements or information. These risks and uncertainties may cause actual results to differ materially from the forward-looking statements or information.

Readers are cautioned that the foregoing list is not exhaustive of all possible risks and uncertainties. Readers are also cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations, and opinions of management on the time such forward-looking information is made. Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

###

Datametrex $DM.ca #AI Pandemic Management System Charting Hotspot Signs Of #COVID19 Outbreaks

Posted by AGORACOM-JC at 12:02 PM on Monday, October 5th, 2020
Webinar logo
  • Announced the development of an advanced statistical model to assess the current state of the pandemic and to monitor COVID-19 hotspots using Artificial Intelligence and Machine Learning
  • As the COVID-19 pandemic continues to spread around the globe, the Company is further developing its Nexalogy AI to build automated tracking systems that will mine vast amounts of data using NexaIntelligence, from social media and traditional news, for signs of new COVID-19 outbreaks being discussed in real-time
  • According to a 2018 study by the McKinsey Global Institute, entitled: Notes from the AI frontier: Applications and value of deep learning, these capabilities are estimated to have the potential to create between approximately $9.5 trillion and $15.4 trillion in annual global economic value

Toronto, Ontario–(October 5, 2020) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”) is pleased to announce the development of an advanced statistical model to assess the current state of the pandemic and to monitor COVID-19 hotspots using Artificial Intelligence (“AI”) and Machine Learning (“ML”).

Prior to the COVID-19 pandemic’s stranglehold on the world, leaders increasingly embraced advanced analytics and AI, for good reason. According to a 2018 study by the McKinsey Global Institute, entitled: Notes from the AI frontier: Applications and value of deep learning, these capabilities are estimated to have the potential to create between approximately $9.5 trillion and $15.4 trillion in annual global economic value.[1]

As the COVID-19 pandemic continues to spread around the globe, the Company is further developing its Nexalogy AI to build automated tracking systems that will mine vast amounts of data using NexaIntelligence, from social media and traditional news, for signs of new COVID-19 outbreaks being discussed in real-time.

Secondly, the Company is developing an early alarm mapping system to keep watch for the pandemic using an advanced ML statistical model to monitor COVID-19 on the Lexical Map. This is developed using automatic text analysis that identifies with coloured clusters the sub-themes to understand COVID-19 noise versus signal quickly and certainly underscores the potential of AI and ML.

Predicting positive results based on scientific mapping brings new developments to treatment in which clusters are systematically screened using computer algorithms for tracking and tracing for viral testing protocols leading to any subsequent quarantining and healthcare that may well be required.

This new system will collect and analyze COVID-19 data from Twitter, Facebook, Tumblr, blogs, web forums, online news sites, Google Alerts and RSS feeds.

“Our AI pandemic management and analytics platform supports the modelling and monitoring of COVID-19. By leveraging smartphones and other digital technology, we use our analytics to produce metrics that help governments and communities evaluate trends to enable strategic and efficient deployment of resources,” said Marshall Gunter, CEO of the Company.

About Datametrex

Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

Certain statements including in this news release contain “forward-looking information” or constitute “forward-looking statements” within the meaning of applicable securities laws. Such forward-looking statements or information are provided for the purpose of providing information about management’s current expectations and plans relating to the future. Readers are cautioned that reliance on such information may not be appropriate for other purposes In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy, including the dollar amount of revenue anticipated under the Agreement.

Forward-looking statements or information are based on current expectations, estimates and projections that involve several risks and uncertainties, which could cause actual results to differ materially from those anticipated by the Company and described in the forward-looking statements or information. These risks and uncertainties may cause actual results to differ materially from the forward-looking statements or information.

Readers are cautioned that the foregoing list is not exhaustive of all possible risks and uncertainties. Readers are also cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the time such forward-looking information is made. Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Datametrex $DM.ca CEO Provides an Update to Shareholders

Posted by AGORACOM-JC at 12:09 PM on Thursday, October 1st, 2020
Webinar logo

Toronto, Ontario–(October 1, 2020) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”) is pleased to provide an update to the market and shareholders from its Chief Executive Officer, Marshall Gunter:

“I believe that it is important for our shareholders to understand our achievements and growth plan.

Since our recent Information Circular for Annual General Meeting (AGM) was registered, there has been much confusion on the topic of a potential consolidation of the shares. The ability to consolidate a company’s share float has been used by many public companies in the past to elevate itself to a larger exchange. Datametrex reserves the right to consolidate our shares, if warranted, for an uplisting to another major exchange. At this time, we do not intend to consolidate the shares nor plan to. We are focused on growing all of the businesses within Datametrex.

We are focused on the expansion of our Artificial Intelligence (AI) business in various verticles. The pace with clients continues to be rapid. This is illustrated with the addition of increased business from global clientele such as LOTTE and 7/11 in South Korea as well as government agencies in both Canada and the United States.

The global markets are demanding seamless solutions to improve their bottom line. We at Datametrex have proven that we enable them to do just that. To have these clients is a real testament to our team of professionals who are working around the clock to secure our future success with our AI suite of services.

We continue to report success within our line of coronavirus solutions. The interest continues to grow, as we have illustrated in our recent press releases. To date, we have been approached by numerous companies across many sectors. I am pleased with what we have achieved.

Our indication of profitability is in a range between 20% and 40%. We deliver secured reporting and testing solutions that are FDA, Health Canada, and CE approved. This gives our clients the capability to support and protect their employees and clients.

Datametrex can adapt and serve the ever-changing coronavirus landscape. It is a terrible situation for our country. We do not take this lightly. I am confident in all the services we are providing. Datametrex will update the market on developments in future communications when material.

We are in the final stages of filing our OTC QB listing in the US. I am glad to state that our filing has been submitted, and our timing is on track with the US regulators.

I thank all of our shareholders who have and continue to support us. We are committed to you. Thank you.”

About Datametrex

Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

Certain statements including in this news release contain “forward-looking information” or constitute “forward-looking statements” within the meaning of applicable securities laws. Such forward-looking statements or information are provided for the purpose of providing information about management’s current expectations and plans relating to the future. Readers are cautioned that reliance on such information may not be appropriate for other purposes In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy, including the dollar amount of revenue anticipated under the Agreement.

Forward-looking statements or information are based on current expectations, estimates and projections that involve several risks and uncertainties, which could cause actual results to differ materially from those anticipated by the Company and described in the forward-looking statements or information. These risks and uncertainties may cause actual results to differ materially from the forward-looking statements or information.

Readers are cautioned that the foregoing list is not exhaustive of all possible risks and uncertainties. Readers are also cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the time such forward-looking information is made. Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Datametrex $DM.ca Expands to Toronto Film Production Company for COVID-19 Testing Solutions

Posted by AGORACOM-JC at 12:14 PM on Wednesday, September 30th, 2020
Webinar logo
  • Received a Purchase Order from a Toronto based film production company, Flatmate Productions Inc., a subsidiary of Cream Production Inc., to provide COVID-19 test kits and related screening solutions
  • Ontario is one of the largest production centres in North America, representing approximately 34% of Canadian based film productions
  • Ontario’s film and television industry had a record-breaking year in 2019, with 343 productions bringing in approximately $2.16 billion in production spending for the economy

Toronto, Ontario–(September 30, 2020) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC: DTMXF) (the “Company” or “Datametrex”) is pleased to announce that it received a Purchase Order (the “PO”) from a Toronto based film production company, Flatmate Productions Inc., a subsidiary of Cream Production Inc., to provide COVID-19 test kits and related screening solutions.

“With Toronto based production companies resuming to filming their projects, we feel that film production companies will be an important market for the Company to sell its COVID-19 tests and related services as Toronto is one of the largest film production locations in North America,” commented Marshall Gunter CEO of the Company.

In this respect, Ontario is one of the largest production centres in North America, representing approximately 34% of Canadian based film productions. Ontario’s film and television industry had a record-breaking year in 2019, with 343 productions bringing in approximately $2.16 billion in production spending for the economy. (Source: Government of Ontario: Record-breaking Year for Ontario’s Film and Television Industry)

Datametrex anticipates that it will have little or no upfront costs associated with importing and selling these test kits pursuant to the terms of the PO.

About Cream

Cream is a Toronto and LA based creative production company. They deliver distinctive and top-rated content to television and digital platforms around the world including Netflix, CNN, Hulu, PBS, Discovery Channel, History Channel, and the BBC. Additional information on Cream is available at www.creamproductions.com

About Datametrex

Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:
Marshall Gunter: CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

Certain statements including in this news release contain “forward-looking information” or constitute “forward-looking statements” within the meaning of applicable securities laws. Such forward-looking statements or information are provided for the purpose of providing information about management’s current expectations and plans relating to the future. Readers are cautioned that reliance on such information may not be appropriate for other purposes In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy, including the dollar amount of revenue anticipated under the Agreement.

Forward-looking statements or information are based on current expectations, estimates and projections that involve several risks and uncertainties, which could cause actual results to differ materially from those anticipated by the Company and described in the forward-looking statements or information. These risks and uncertainties may cause actual results to differ materially from the forward-looking statements or information.

Readers are cautioned that the foregoing list is not exhaustive of all possible risks and uncertainties. Readers are also cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the time such forward-looking information is made. Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Datametrex $DM.ca Signs Agreement with Major Worldwide Media & Entertainment Company for COVID-19

Posted by AGORACOM-JC at 9:32 AM on Thursday, September 24th, 2020
Webinar logo
  • Company anticipating that the aggregate dollar amount of revenue under this Agreement is expected to be over CAD $20MM for the initial nine (9) months, given the anticipated demand for COVID-19 testing and related services
  • Services to be completed pursuant to this Agreement are scheduled to commence immediately
  • Datametrex anticipates that it will have little or no upfront costs associated with importing and selling these test kits
  • The Company is one of the largest media and entertainment groups with multiple subsidiaries and a worldwide presence

Toronto, Ontario–(September 24, 2020) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”) is pleased to announce it has entered into a service agreement (the “Agreement”), dated September 21, 2020 with one of the world’s largest media and entertainment groups for its theatrical film and TV shows in both Vancouver and Toronto. Pursuant to the terms of the Agreement, the Company will provide COVID-19 tests with test kits and related services as and when required through subsequent statements of work that will set out the specific scope of services and the dollar amounts for the various projects.

The Company will issue subsequent press releases as when these statements of work are entered into under the Agreement which will disclose the material terms and conditions of such services. Based on current discussions that management of the Company is having with this Media and Entertainment company, it is anticipating that the aggregate dollar amount of revenue under this Agreement is expected to be over CAD $20MM for the initial nine (9) months, given the anticipated demand for COVID-19 testing and related services. There is no assurance or guarantee that the dollar amount of services under this Agreement will result in this or any amount of revenue for the Company.

The services to be completed pursuant to this Agreement are scheduled to commence immediately. Datametrex anticipates that it will have little or no upfront costs associated with importing and selling these test kits. The Company is one of the largest media and entertainment groups with multiple subsidiaries and a worldwide presence.

According to PwC’s Global Entertainment & Media (E&M”) Outlook, the COVID-19 pandemic has accelerated and amplified ongoing shifts in consumers’ behaviour, pulling forward digital disruption and forging industry tipping points that would not have been reached for many years.

As a result, the E&M world in 2020 has become more remote, more virtual, more streamed, more personal and – for now at least – more centred on the home. Winners and losers will emerge based on their ability to leverage enabling technology to deliver truly distinctive content and experience options, while navigating regulatory and privacy hurdles. [1]

Vancouver is the third-largest production centre in North America, worth approximately CDN $3.2 billion during 2018/19, according to Creative BC. British Columbia is home to several world-class film and TV studios, including Bridge Studios, Mammoth Studios, Vancouver Film Studios, North Shore Studios, Ironwood Studios, Canadian Motion Picture Park, and The Crossing Studios.

The entire film and TV production in Canada represents approximately $8.92 billion in production volume, and 179,000 full-time equivalent jobs. In March 2020, the industry stopped worldwide.Vancouver and the surrounding areas had 46 productions filming, representing 37% of all Canadian productions, not including the TV commercial market. Each of the shows had a minimum of a 100-person film crew.

The next largest film and television market is Ontario, representing 34% of all Canadian productions. In 2019, Toronto’s film and television industry directly employed more than 28,000 people tallying approximately $3.17 Billion.

Additionally, with Canada having far fewer instances of COVID-19 cases than in the United States on a per capita basis according to data compiled by Johns Hopkins University, it demonstrates that Canada is a safer jurisdiction for filming, with our testing kits, collection services and labs already set up.

“With Vancouver productions quickly returning to the studios and filming, we feel that this is the tip of the iceberg for new COVID-19 screening in the production industry”, said Marshall Gunter, CEO of the Company.

About Datametrex

Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

Certain statements including in this news release contain “forward-looking information” or constitute “forward-looking statements” within the meaning of applicable securities laws. Such forward-looking statements or information are provided for the purpose of providing information about management’s current expectations and plans relating to the future. Readers are cautioned that reliance on such information may not be appropriate for other purposes In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy, including the dollar amount of revenue anticipated under the Agreement.

Forward-looking statements or information are based on current expectations, estimates and projections that involve several risks and uncertainties, which could cause actual results to differ materially from those anticipated by the Company and described in the forward-looking statements or information. These risks and uncertainties may cause actual results to differ materially from the forward-looking statements or information.

Readers are cautioned that the foregoing list is not exhaustive of all possible risks and uncertainties. Readers are also cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the time such forward-looking information is made. Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Datametrex $DM.ca Receives Third COVID-19 Order from TV Production Company

Posted by AGORACOM-JC at 9:19 AM on Monday, September 21st, 2020
Webinar logo
  • Announced that it has received a third Purchase Order for COVID-19 screening solutions from Are You Afraid of the Dark Inc., a Canadian horror anthology television miniseries based in Vancouver, British Columbia.
  • The initial P.O. is for approximately $210,000 for a month, commencing on October 5, 2020
  • This production is scheduled to run for three (3) months, totalling $630,000.
  • Datametrex anticipates that it will have little or no upfront costs associated with importing and selling these test kits

Toronto, Ontario–(September 21, 2020) –  Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”) is pleased to announce that it has received a third Purchase Order (“P.O.”) for COVID-19 screening solutions from Are You Afraid of the Dark Inc., a Canadian horror anthology television miniseries based in Vancouver, British Columbia.

The miniseries is produced by Nickelodeon Productions and distributed by MTV Networks in the United States and YTV in Canada, a Corus Entertainment company. Nickelodeon, now in its 41st year, is the number one entertainment brand for kids. Nickelodeon and all related titles, characters and logos are trademarks of Viacom Inc.

The initial P.O. is for approximately $210,000 for a month, commencing on October 5, 2020. This production is scheduled to run for three (3) months, totalling $630,000. Datametrex anticipates that it will have little or no upfront costs associated with importing and selling these test kits.

As previously stated, Vancouver is the third-largest production centre in North America, worth CDN $3.2 Billion during 2018/19, according to Creative BC. British Columbia is home to several world-class Film and TV studios, including Bridge Studios, Mammoth Studios, Vancouver Film Studios, North Shore Studios, Ironwood Studios, Canadian Motion Picture Park, and The Crossing Studios.

Entire film and TV production in Canada represent $8.92 Billion in production volume, and full-time equivalent jobs represent 179,000 workers. In March 2020, the industry stopped worldwide, including in Vancouver, which represents 37% of Canadian Productions. The surrounding areas of Vancouver had 46 productions filming, which does not include the TV commercial market. Each of the shows potentially had a minimum of 100 people in their film crew.1

The next largest film and television market is Ontario, which represents 34% of Canadian productions. In 2019, Toronto’s film and television industry directly employed more than 28,000 people representing $3.17 Billion in production volume.

Additionally, with Canada having far fewer cases of COVID-19 than in the United States on a per capita basis according to data compiled by Johns Hopkins University, it demonstrates that Canada is a safer jurisdiction for filming and an advocate for the film industry, with our testing kits, collection services and labs already set up.

“With Vancouver productions quickly returning to the studios and filming, we feel that this is the tip of the iceberg for new film business for COVID-19 screening business,” said Marshall Gunter, CEO of the Company.

About Datametrex

Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:
Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not historical may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the time such forward-looking information is made. Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Datametrex $DM.ca Receives Second COVID-19 Order from Film & TV Production Company

Posted by AGORACOM-JC at 9:11 AM on Wednesday, September 16th, 2020
Webinar logo
  • Received second Purchase Order (P.O.) for COVID-19 screening solutions with Lighthouse Pictures Inc., a Film and Television production company based in Vancouver, British Columbia
  • The service is scheduled to commence on September 16, 2020.
  • Datametrex anticipates that it will have little or no upfront costs associated with importing and selling these test kits

Toronto, Ontario–(September 16, 2020) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC: DTMXF) (the “Company” or “Datametrex”) is pleased to announce it has received second Purchase Order (P.O.) for COVID-19 screening solutions with Lighthouse Pictures Inc., a Film and Television production company based in Vancouver, British Columbia. The service is scheduled to commence on September 16, 2020. Datametrex anticipates that it will have little or no upfront costs associated with importing and selling these test kits.

Lighthouse Pictures is a company that specializes in producing genre and mid-to small-budget film and television projects. Industry leaders Shawn Williamson and Jamie Goehring helm Lighthouse Pictures. With over 65 productions in the past ten years, Lighthouse Pictures productions continue to be recognized. Year after year, Lighthouse projects have received industry praise with Canadian Screen Awards nominations, and numerous Leo Awards.

Vancouver is the third-largest production centre in North America, worth CDN $3.2 Billion during 2018/19, according to Creative BC. British Columbia is home to several world-class Film and TV studios, including Bridge Studios, Mammoth Studios, Vancouver Film Studios, North Shore Studios, Ironwood Studios, Canadian Motion Picture Park, and The Crossing Studios.

They all produce, on average, approximately 65+ movies and 55+ TV series annually, as well as hundreds of other filming days for commercials, TV pilots and other features. This industry generates over 42,000 direct and indirect jobs in Film and TV production, with more than 80 percent located in Metro Vancouver. British Columbia is world-renowned as a versatile and dependable hub for motion picture production.

Entire film and TV production in Canada represent $8.92 Billion in production volume, and full-time equivalent jobs represent 179,000 workers. In March 2020, the industry stopped in Vancouver, and the surrounding areas had 46 productions filming which does not include the TV commercial market. Each of the shows would have a minimum of a 100-person film crew. (source: https://www.creativebc.com/about-us/research-and-reports/index)

This demonstrates that Canada can be an advocate for the Film industry, as we have testing and labs already set up throughout. Additionally, Canada has far fewer instances of coronavirus with 139,146 cases, compared with more than 6,545,948 in the US, according to data compiled by Johns Hopkins University.

“With our pre-screening and screening tools, this industry can resume and provide us with the much-needed entertainment that this newly indoor, online-based culture requires”, said Marshall Gunter CEO of the Company.

These tools were developed as a direct response to customer needs and the ever-changing physical distancing recommendations, safety guidelines, and workplace flexibility initiatives being observed across North America and around the globe.

About Datametrex

Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:
Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not historical may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the time such forward-looking information is made. Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

###

DataMetrex $DM.ca Secures Contract with 7-Eleven

Posted by AGORACOM-JC at 8:14 AM on Thursday, September 10th, 2020
Webinar logo
  • Announced that it has entered into a sales agreement with 7-Eleven Korea for Robotic Process Automation infrastructure.
  • RPA is the technology that enables anyone to configure computer software today, or a “robot” to replicate and incorporate the actions of a person working within digital systems to conduct a business process
  • Global RPA market size is expected to reach $7.2 billion by 2025, rising at a market growth of 32.6% CAGR during the forecast period

Toronto, Ontario–(September 10, 2020) –  Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex“) is pleased to announce that it has entered into a sales agreement with 7-Eleven Korea for Robotic Process Automation (“RPA”) infrastructure.

The global RPA market size is expected to reach $7.2 billion by 2025, rising at a market growth of 32.6% CAGR during the forecast period. RPA is the technology that enables anyone to configure computer software today, or a “robot” to replicate and incorporate the actions of a person working within digital systems to conduct a business process. An increased demand for business process automation (“BPA”) is expected to be the main growth driver through the use of Artificial Intelligence (“AI”) and RPA.[1]

7-Eleven is a international chain of convenience stores founded in 1927 in the United States with over 70,000 stores located around the globe. 7-Eleven has a legacy of innovation and delivering “what the customers want, when and where they want it.”

Datametrex is working closely with clients to power it through their digital initiatives and improve their delivery on innovation as they continue the pursuit of catering to a modern, digital-savvy generation of shoppers.

“At Datametrex, we continue our efforts to facilitate ground-breaking technologies to companies across the globe. Our technology is proven to be valuable to make sense of the data beyond complicated spreadsheets.” said Marshall Gunter, CEO of Datametrex. “We pride ourselves in providing tools that our clients can use to visualize their customer and stakeholder data. Through predictive analysis they can support their decision making, mitigate risk, and improve their bottom line.”

Investor Webinar

Datametrex also announces that senior management will be hosting an investor update webinar on Tuesday, September 15, 2020, at 1:00 p.m. ET to discuss the Company’s Second Quarter 2020 results, developments and contracts on the Artificial Intelligence technologies and COVID-19 test kits.

Webinar Details:

Date: Tuesday, September 15, 2020

Time: 1:00 p.m. ET

Registration Link: https://us02web.zoom.us/webinar/register/WN_FZc3a5nlQiKlsTEq5bqFfQ?t=1599612433950

Datametrex plans to answer questions previously sent to [email protected] and during the webinar, at management’s discretion and subject to time constraints.

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.____________________________________

[1] Source: Global Robotic Process Automation Market By Component By Organization Size By Deployment Type By End User By Region, Industry Analysis and Forecast, 2019 – 2025NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES